M1 Kliniken AG (FRA:M12)
Germany
· Delayed Price · Currency is EUR | Market Cap | 338.45M |
| Revenue (ttm) | 354.98M |
| Net Income (ttm) | 17.74M |
| Shares Out | n/a |
| EPS (ttm) | 0.95 |
| PE Ratio | 19.08 |
| Forward PE | 19.38 |
| Dividend | 0.50 (2.62%) |
| Ex-Dividend Date | Jul 17, 2025 |
| Volume | n/a |
| Average Volume | 142 |
| Open | 19.12 |
| Previous Close | 19.26 |
| Day's Range | 19.12 - 19.12 |
| 52-Week Range | 12.88 - 19.26 |
| Beta | n/a |
| RSI | 74.81 |
| Earnings Date | Dec 11, 2025 |
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; abdominoplastic and nose correction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segmen... [Read more]
Financial Performance
In 2024, M1 Kliniken AG's revenue was 339.18 million, an increase of 7.23% compared to the previous year's 316.32 million. Earnings were 16.02 million, an increase of 55.91%.
Financial StatementsNews
M1 Kliniken AG: 11% EBIT Surge, EPS Hits €0.86
M1 Kliniken AG's financial performance in 2025 highlights strategic growth, with significant gains in the Beauty segment and plans for future expansion.
EQS-News: M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86.
EQS-News: M1 Kliniken AG / Key word(s): 9 Month figures/Quarter Results M1 Kliniken AG reports strong EBIT Growth of 11% and achieves Earnings per Share of EUR 0.86. 18.11.2025 / 08:30 CET/CEST The is...
EQS-Adhoc: M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group
EQS-Ad-hoc: M1 Kliniken AG / Key word(s): Disposal/Investment M1 Kliniken AG: M1 Kliniken AG: HAEMATO AG sells its 100% subsidiary HAEMATO Pharm GmbH to PHOENIX group 16-Oct-2025 / 18:39 CET/CEST Disc...
M1 Kliniken: H1 Success with 24% EBIT Growth, EPS Hits €0.63
M1 Kliniken AG shines in the first half of 2025, showcasing impressive growth and strategic expansion. With a 24% EBIT surge and earnings per share reaching EUR 0.63, the company marks a successful pe...
M1 Kliniken's Q1 2025: 29% EBIT Surge, EPS Hits €0.31
M1 Kliniken AG dazzles with robust Q1 2025 results, driven by strategic growth and ambitious expansion plans. Jetzt den vollständigen Artikel lesen
EQS-News: M1 Kliniken AG: Strong Q1 2025 with 29% EBIT Growth and Earnings per Share of EUR 0.31
EQS-News: M1 Kliniken AG / Key word(s): Quarter Results/Quarterly / Interim Statement M1 Kliniken AG: Strong Q1 2025 with 29% EBIT Growth and Earnings per Share of EUR 0.31 05.06.2025 / 08:30 CET/CEST...